SEC fundamentals
VYNE Therapeutics Inc. (YARW)
as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗
Quarter-end price
Derived from SEC filings · not a live quote · USD per share
35 quarter-ends on file; the newest 4 shown. Each price is as of its date, from the filings that reported it, and is never adjusted; the full series with each price's sources is in the docs.
In its 10-Q for the period ended Sep 30, 2026, VYNE Therapeutics Inc. reported net income of -$9.7M and total assets of $274.0M. VYNE Therapeutics Inc. carries no long-term debt on its most recent balance sheet. Every figure below is taken directly from VYNE Therapeutics Inc.'s SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2016–FY2025 · as reported
- FY2016 revenue
- $674,000
- FY2025 revenue
- $570,000
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $570,000 | -$26.5M |
| FY2024 | $501,000 | -$39.8M |
| FY2023 | $424,000 | -$28.5M |
| FY2022 | $477,000 | -$23.2M |
| FY2021 | $931,000 | -$73.3M |
| FY2020 | $21.0M | -$255.6M |
| FY2019 | $443,000 | -$95.2M |
| FY2018 | $10.6M | -$74.2M |
| FY2017 | $4.6M | -$29.1M |
| FY2016 | $674,000 | -$14.1M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 10-Q | Nov 13, 2026 | on EDGAR ↗ |
| 8-K | Nov 12, 2026 | on EDGAR ↗ |
| 8-K | Sep 14, 2026 | on EDGAR ↗ |
| 8-K | Sep 10, 2026 | on EDGAR ↗ |
| 10-Q | Aug 13, 2026 | on EDGAR ↗ |
| 8-K | Jul 30, 2026 | on EDGAR ↗ |
| 8-K | Jul 28, 2026 | on EDGAR ↗ |
| 8-K | Jul 21, 2026 | on EDGAR ↗ |
| 8-K | Jul 20, 2026 | on EDGAR ↗ |
| 8-K | Jul 14, 2026 | on EDGAR ↗ |
Balance Sheet
as of Sep 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Sep 30, 2026
Per Share & Cash Flow
10-Q (quarterly) · period ended Sep 30, 2026
| EPS (diluted) | $-0.43 | Earnings | source ↗ |
| EPS (basic) | $-0.43 | Earnings | source ↗ |
| Shares Outstanding | 15.2M | Entity | source ↗ |
| Cash from Operations | -$90.0M | Net | source ↗ |
| Cash from Financing | $265.0M | Net | source ↗ |
| Cash from Investing | — | — | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
No open-market Form 4 transactions filed in the last 180 days.
Restatement history
Point-in-time31 of 259 annual fact-keys were materially restated between filings: what VYNE Therapeutics Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches YARW’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Starter extends the ratios to 20 quarters and adds the Piotroski F-score and accruals quality score; Analyst extends the trajectory to up to 20 years. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Starter removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/YARW
MCP tool:
get_sec_fundamentals ticker=YARW - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/YARW/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=YARW as_of=YYYY-MM-DD - Quarter-end prices derived from SEC filings, with their sources and splits
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/prices/YARW/history?frequency=quarter
MCP tool:
get_sec_price_history ticker=YARW frequency=quarter - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/YARW/history
MCP tool:
get_fundamentals_history ticker=YARW - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/YARW
MCP tool:
get_financial_health ticker=YARW
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.